IP Library Granted Patent US 8,957,191
Granted Patent B2
US 8,957,191 · App. 13/003,410 · Granted Feb 17, 2015

Nucleic acid comprising zwitterionic nucleotides

Inventor: Steffen Panzner (Halle, DE)
Assignee: Steffen Panzner
C07H21/04A61K47/48038A61K47/48046A61K47/48061A61K47/48123C07H21/00C07H21/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,957,191
App. No.
13/003,410
Granted
Feb 17, 2015
Kind
B2
Abstract

This invention provides pH-responsive zwitterionic nucleotides and nucleic acids comprising said nucleotides, wherein said zwitterions are constituted from one or more anionic internucleoside linkages and one or more cationic moieties and said zwitterionic nucleotides further comprise either one or more hydrophobic moieties or one or more TEE's with the general structure (I) Hydrophobic element-pH-responsive hydrophilic elements (I).

Claims (17)

1. Nucleic acid comprising pH-responsive zwitterionic nucleotides of the following formula:

wherein

B is a nucleobase selected from adenine, guanine, thymine, cytosine or uracil;

Y is oxygen or sulphur;

n (number of nucleotides) is >=2;

CM is a cationic moiety which is a nitrogen base having a pK equal to or greater than 7.5 or a constantly charged cationic moiety comprising an ammonium or guanidinium group; and

TEE stands for a transfection enhancer element having the general formula (I):

Hydrophobic element-pH-responsive hydrophilic elements  (I),

wherein said hydrophobic element is a linear, branched or cyclic chain comprising 6 to 40 carbon atoms in the form of hydrocarbons or methylene groups, and said pH-responsive hydrophilic element is a carboxylic acid.

2. The nucleic acid according to claim 1 , wherein said hydrophobic element of said TEE comprises more than 6 and up to 40 carbon atoms.

3. The nucleic acid according to claim 1 , wherein said hydrophobic element of said TEE comprises from 6 to 22 carbon atoms.

4. The nucleic acid according to claim 1 , wherein said hydrophobic element is a hydrocarbon group.

5. The nucleic acid according to claim 1 , wherein said hydrophobic element consists of methylene groups.

6. The nucleic acid according to claim 1 , wherein said nucleotides are selected from the following structures wherein CiH2i is a hydrocarbon chain having the length i:

7. The nucleic acid according to claim 1 , wherein said hydrophobic element of said TEE is directly attached to moiety CM.

8. The nucleic acid according to claim 1 , wherein no more than ⅔ of all nucleotides in said nucleic acid are of IPN type.

9. The nucleic acid according to claim 1 , wherein about 50% of all nucleotides in said nucleic acid are of IPN type.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2020
From: PANZNER, STEFFEN
To: BIONTECH PROTEIN THERAPEUTICS GMBH
Reel/Frame 052958/0769 →
CHANGE OF NAME Recorded Jun 16, 2020
From: BIONTECH PROTEIN THERAPEUTICS GMBH
To: BIONTECH DELIVERY TECHNOLOGIES GMBH
Reel/Frame 052958/0773 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2014
From: LIPOCALYX GMBH
To: PANZNER, STEFFEN
Reel/Frame 034457/0596 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2011
From: PANZNER, STEFFEN
To: LIPOCALYX GMBH
Reel/Frame 027319/0498 →
Priority Claims (1)
EP 08104731 · Jul 11, 2008 · regional
Continuity (1)
Related Publication 20110137019A1 · Jun 9, 2011